Rangan (Ronnie) Maitra

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Novel peripherally selective cannabinoid receptor 1 neutral antagonist improves metabolic dysfunction-associated steatotic liver disease in mice

The monoacylglycerol lipase inhibitor ABX-1431 does not improve alcoholic liver disease

Heterocyclic apelin receptor (APJ) agonists and uses thereof

Discovery of 1,3-disubstituted pyrazole peripheral cannabinoid receptor partial agonists

Apelin receptor (APJ) agonists and uses thereof

Improvement of the metabolic stability of GPR88 agonist RTI-13951-33: Design, synthesis, and biological evaluation

Apelin receptor (APJ) agonists and uses thereof

Recent advances in the development of small-molecule apelin receptor agonists for cardiovascular and metabolic diseases

Structure-activity relationship development efforts towards peripherally selective analogs of the cannabinoid receptor partial agonist BAY 59-3074

Apelin receptor (APJ) agonists and uses thereof

Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin receptor

Evaluation of amide bioisosteres leading to 1,2,3-triazole containing compounds as GPR88 agonists: Design, synthesis, and structure-activity relationship studies

"Photo-Rimonabant": Synthesis and biological evaluation of novel photoswitchable molecules derived from Rimonabant lead to a highly selective and nanomolar "Cis-On" CB1R antagonist

Peripherally selective CB1 receptor antagonist improves symptoms of metabolic syndrome in mice

Pyrazole agonist of the apelin receptor improves symptoms of metabolic syndrome in mice

Apelin receptor (APJ) agonists and uses thereof

Aplnr knockout mice display sex-specific changes in conditioned fear

Design, synthesis, and structure-activity relationship studies of (4-alkoxyphenyl)glycinamides and bioisosteric 1,3,4-oxadiazoles as GPR88 agonists

Behavioral assessment of rimonabant under acute and chronic conditions

Diaryl purine derivatives with improved bioavailability